Skip to main content

Sigma-Aldrich, US Genomics

Premium

Sigma-Aldrich recently announced that it has released new additions to its Mission TRC RNAi product line. These additions bring the current number of vector constructs offered to 50,000, targeting 7,100 human and 2,900 mouse genes, the company said.

The constructs are available as frozen bacterial glycerol stocks or transfection grade plasmid DNA, Sigma-Aldrich said.

Additional information about the Mission RNAi products can be found at http://www.sigmaaldrich.com/Area_of_Interest/Life_Science/RNA_Interference_RNAi.html.


US Genomics has recently unveiled its Direct Results fee-for-service program, which allows researchers to use single molecule technology to accurately quantitate the microRNAs in their samples.

According to the company, the new service uses the Trilogy 2020 single molecule analyzer to enable scientists to detect individual molecules of miRNA with Direct miRNA assays.

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.